COLLEGIUM PHARMACEUTICAL INC. - COMMON STOCK

Collegium to Participate in Upcoming Investor Conferences

12 11 2024 07:00:01 提供 Nasdaq GlobeNewswire

Collegium Reports Record Third Quarter 2024 Financial Results

07 11 2024 15:02:00 提供 Nasdaq GlobeNewswire

Collegium Appoints Vikram Karnani as Chief Executive Officer

07 11 2024 15:01:00 提供 Nasdaq GlobeNewswire

Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024

24 10 2024 07:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: COLLEGIUM PHARMACEUTICAL INC. - COMMON STOCK

07 10 2024 08:45:26 提供 NetDania Notify

NetDania - New 12 months High: COLLEGIUM PHARMACEUTICAL INC. - COMMON STOCK

04 10 2024 09:14:59 提供 NetDania Notify

Collegium Completes Acquisition of Ironshore Therapeutics

04 9 2024 07:00:00 提供 Nasdaq GlobeNewswire

Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference

30 8 2024 07:00:00 提供 Nasdaq GlobeNewswire

Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024

28 8 2024 07:00:00 提供 Nasdaq GlobeNewswire

Collegium Reports Second Quarter 2024 Financial Results

08 8 2024 15:01:00 提供 Nasdaq GlobeNewswire

Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology

29 7 2024 05:00:00 提供 Nasdaq GlobeNewswire

Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024

25 7 2024 07:00:00 提供 Nasdaq GlobeNewswire

Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise

13 6 2024 07:00:00 提供 Nasdaq GlobeNewswire

Collegium to Participate in Jefferies Global Healthcare Conference

29 5 2024 07:00:01 提供 Nasdaq GlobeNewswire

Collegium Announces $35 Million Accelerated Share Repurchase Program

13 5 2024 07:00:00 提供 Nasdaq GlobeNewswire

Collegium Reports First Quarter 2024 Financial Results

09 5 2024 15:02:00 提供 Nasdaq GlobeNewswire

Collegium Announces CEO Transition

09 5 2024 15:01:00 提供 Nasdaq GlobeNewswire

Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER

29 4 2024 07:00:00 提供 Nasdaq GlobeNewswire

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

25 4 2024 07:00:00 提供 Nasdaq GlobeNewswire

Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026

11 4 2024 07:00:00 提供 Nasdaq GlobeNewswire